Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Clinical trial NCT03364153 · COMPLETED

Trial details

NCT number: NCT03364153
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stargardt's Macular Dystrophy

Start date: 2018-01-12
Primary completion: 2025-03-31
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.